Century Health Raises $5M to Scale Clinical Data Platform for Drug Research
Century Health, which automates the extraction of clinical data for pharmaceutical research, has closed a $5 million seed round led by Origin Ventures. The company's AI platform achieves 97% accuracy when validated against clinical experts-the standard pharma companies use to evaluate data for research and regulatory decisions.
The funding comes as drug developers face a critical shortage. Years of AI investment in life sciences have exhausted most publicly available biomedical datasets. High-quality, structured clinical records from real patients are now scarce, and companies need them for drug discovery, trial design, and patient stratification.
Century Health's CHARM platform automates what has traditionally required manual work: extracting and organizing patient information from unstructured clinical notes, radiology reports, and electronic health records. The company grew its provider network 60-fold over the past year, now spanning neurology, nephrology, ophthalmology, respiratory, metabolic, and immunology specialties.
Multiple top-five pharmaceutical companies already use the platform. The round included participation from InnovateHealth Ventures, 25madison, Next Play Ventures, 2048 Ventures, and Alumni Ventures, plus strategic angels including Zorba Lieberman, founder of Citeline.
Century Health plans to use the funding to expand its specialty provider network, deepen partnerships with pharma companies, and build out its data infrastructure for more complex abstraction and data harmonization work.
"Structuring clinical data historically required extensive manual work that can now be automated and scaled," said Vish Srivastava, CEO and co-founder. "This funding lets us expand our network, go deeper into priority disease areas, and generate the critical evidence that shapes patient care."
The company operates at the intersection of two pressing needs: providers have rich clinical data but lack the resources to organize it for research, while pharmaceutical companies need that data to advance drug development. Century Health's model creates what the company calls a "win-win" - providers get compensated for data access, pharma companies get research-ready datasets, and patients benefit from faster therapeutic development.
For healthcare professionals involved in clinical research, data management, or pharmaceutical partnerships, understanding how clinical data infrastructure is evolving matters. Learn more about AI data analysis applications in healthcare and AI for healthcare more broadly.
Your membership also unlocks:
